Electromed Balance Sheet Health
Financial Health criteria checks 6/6
Electromed has a total shareholder equity of $41.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $48.9M and $7.4M respectively. Electromed's EBIT is $8.4M making its interest coverage ratio -14.6. It has cash and short-term investments of $13.9M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -14.6x |
| Cash | US$13.86m |
| Equity | US$41.49m |
| Total liabilities | US$7.43m |
| Total assets | US$48.92m |
Recent financial health updates
No updates
Recent updates
What Percentage Of Electromed, Inc. (NYSEMKT:ELMD) Shares Do Insiders Own?
Mar 07
Is Electromed, Inc.'s (NYSEMKT:ELMD) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 17
Should You Be Impressed By Electromed's (NYSEMKT:ELMD) Returns on Capital?
Feb 02Did Electromed, Inc. (NYSEMKT:ELMD) Insiders Sell Shares?
Jan 21Electromed (NYSEMKT:ELMD) Is Growing Earnings But Are They A Good Guide?
Jan 09Here's Why I Think Electromed (NYSEMKT:ELMD) Might Deserve Your Attention Today
Dec 28Electromed, Inc.'s (NYSEMKT:ELMD) Intrinsic Value Is Potentially 90% Above Its Share Price
Dec 16Announcing: Electromed (NYSEMKT:ELMD) Stock Soared An Exciting 405% In The Last Five Years
Dec 04How Is Electromed's (NYSEMKT:ELMD) CEO Paid Relative To Peers?
Nov 22Financial Position Analysis
Short Term Liabilities: ELMD's short term assets ($41.0M) exceed its short term liabilities ($7.4M).
Long Term Liabilities: ELMD's short term assets ($41.0M) exceed its long term liabilities ($8.0K).
Debt to Equity History and Analysis
Debt Level: ELMD is debt free.
Reducing Debt: ELMD had no debt 5 years ago.
Debt Coverage: ELMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ELMD has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/24 22:50 |
| End of Day Share Price | 2025/01/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Electromed, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Feltl and Company, Inc. |
| Brooks O'Neil | Lake Street Capital Markets, LLC |
| James Terwilliger | Northland Capital Markets |